ETV Bharat / science-and-technology

TB vaccine may have protective effect against Alzheimer's: Study

According to a recent study, TB vaccines may have protective effects against Alzheimer's Disease.

TB vaccine may have protective effect against Alzheimer's: Study
TB vaccine may have protective effect against Alzheimer's: Study
author img

By

Published : May 22, 2023, 3:15 PM IST

New Delhi: Treatment with the Bacillus Calmette-Guerin (BCG) vaccine which prevents tuberculosis associated with a reduced risk of Alzheimer's disease and related dementias, according to a study. The BCG vaccine has been found to offer multiple beneficial effects, and is currently a recommended therapy for nonmuscle-invasive bladder cancer, the researchers said.

The team at Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH), US followed 6,467 individuals for up to 15 years after they were diagnosed with nonmuscle-invasive bladder cancer. The group included 3,388 patients who underwent BCG vaccine treatment and 3,079 who served as controls, matched by factors such as age, sex, and medical co-morbidities.

Also read: Study links genetic predisposition for high BP, cholesterol to Alzheimer's

During follow-up, the study published in the journal JAMA Network Open found that 202 patients in the BCG vaccine group and 262 in the control group developed Alzheimer's disease and related dementias. The incidence was 8.8 per 1,000 person-years and 12.1 per 1,000 person-years in the respective groups, the researchers said. Analyses revealed that treatment with the BCG vaccine was associated with a 20 per cent lower risk of Alzheimer's disease and related dementias.

The protective association was greater in patients aged 70 years or older. Additionally, during follow-up, 751 patients in the BCG vaccine group and 973 in the control group died. Treatment with BCG vaccine was associated with a 25 per cent lower risk of death, according to the researchers.

"A vaccine like BCG, if proven effective, is a perfect example of a cost-effective, population-health-based solution to a devastating illness like Alzheimer's disease," said Weinberg. "We are shifting our focus towards studying the potential benefits of BCG vaccination of older adults in Alzheimer's disease-related clinical trials," he added. Weinberg and his colleagues noted that if a causal link is found, it will be important to understand the mechanisms involved, adding the BCG vaccine's effects on the immune system may play a role. (PTI)

New Delhi: Treatment with the Bacillus Calmette-Guerin (BCG) vaccine which prevents tuberculosis associated with a reduced risk of Alzheimer's disease and related dementias, according to a study. The BCG vaccine has been found to offer multiple beneficial effects, and is currently a recommended therapy for nonmuscle-invasive bladder cancer, the researchers said.

The team at Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH), US followed 6,467 individuals for up to 15 years after they were diagnosed with nonmuscle-invasive bladder cancer. The group included 3,388 patients who underwent BCG vaccine treatment and 3,079 who served as controls, matched by factors such as age, sex, and medical co-morbidities.

Also read: Study links genetic predisposition for high BP, cholesterol to Alzheimer's

During follow-up, the study published in the journal JAMA Network Open found that 202 patients in the BCG vaccine group and 262 in the control group developed Alzheimer's disease and related dementias. The incidence was 8.8 per 1,000 person-years and 12.1 per 1,000 person-years in the respective groups, the researchers said. Analyses revealed that treatment with the BCG vaccine was associated with a 20 per cent lower risk of Alzheimer's disease and related dementias.

The protective association was greater in patients aged 70 years or older. Additionally, during follow-up, 751 patients in the BCG vaccine group and 973 in the control group died. Treatment with BCG vaccine was associated with a 25 per cent lower risk of death, according to the researchers.

"A vaccine like BCG, if proven effective, is a perfect example of a cost-effective, population-health-based solution to a devastating illness like Alzheimer's disease," said Weinberg. "We are shifting our focus towards studying the potential benefits of BCG vaccination of older adults in Alzheimer's disease-related clinical trials," he added. Weinberg and his colleagues noted that if a causal link is found, it will be important to understand the mechanisms involved, adding the BCG vaccine's effects on the immune system may play a role. (PTI)

ETV Bharat Logo

Copyright © 2024 Ushodaya Enterprises Pvt. Ltd., All Rights Reserved.